CN103585373A - Drug composition for treating rhinitis - Google Patents

Drug composition for treating rhinitis Download PDF

Info

Publication number
CN103585373A
CN103585373A CN201310588357.1A CN201310588357A CN103585373A CN 103585373 A CN103585373 A CN 103585373A CN 201310588357 A CN201310588357 A CN 201310588357A CN 103585373 A CN103585373 A CN 103585373A
Authority
CN
China
Prior art keywords
grams
gram
rhinitis
drug composition
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310588357.1A
Other languages
Chinese (zh)
Inventor
钱家美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310588357.1A priority Critical patent/CN103585373A/en
Publication of CN103585373A publication Critical patent/CN103585373A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention belongs to a drug composition for treating rhinitis. The drug composition comprises the following raw materials by weight: 20-40 g of dandelion, 15-30 g of golden cypress, 20-40 g of ligusticum wallichii, 20-40 g of dried orange peels, 15-30 g of pinellia ternate, 20-40 g of aster, 15-30 g of radices trichosanthis, 1-5 g of menthol, 0.5-4 g of muscone, 1-5 g of borneol, 1-5 g of diphenhydramine, 1-5 g of camphor, 3-6 g of methyl salicylate and 3-7 g of a belladonna liquid extract. The raw materials also can be prepared into ointments according to a conventional preparation method. The drug composition is used for treating the rhinitis, has a good effect and is free from toxic and side effects.

Description

A kind of pharmaceutical composition for the treatment of rhinitis
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of rhinitis.
Background technology
Rhinitis refers to the inflammation of nasal membrane and submucous tissue.Show as hyperemia or edema, patient often there will be the symptoms such as nasal obstruction, snivel, rhinocnesmus, throat's discomfort, cough.Commonly encountered diseases clinically, frequently-occurring disease, and obstinate difficult healing.At present, the method for the treatment of rhinitis is by antibiotic, antihistaminic and Chinese medicine as treatments such as BIYANKANG, HUODAN WAN, and laser and operative treatment for serious need, but effect is all not too obvious, and be difficult for treatment recovery from illness, bring very large misery to patient.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of pharmaceutical composition for the treatment of rhinitis, requires the effective of said composition treatment rhinitis, and there is no toxic and side effects.
For solving the problems of the technologies described above, the invention provides a kind of pharmaceutical composition for the treatment of rhinitis, comprise the crude drug of following weight portion: Herba Taraxaci 20-40 gram, Cortex Phellodendri 15-30 gram, Rhizoma Chuanxiong 20-40 gram, Pericarpium Citri Reticulatae 20-40 gram, Rhizoma Pinelliae 15-30 gram, Radix Asteris 20-40 gram, Radix Trichosanthis 15-30 gram, Mentholum 1-5 shell, artificial Moschus 0.5-4 gram, Borneolum Syntheticum 1-5 gram, diphenhydramine 1-5 gram, Camphora 1-5 gram, methyl salicylate 3-6 gram, Semen daturae fluid extract 3-7 gram.
As optimization of the present invention, described a kind of pharmaceutical composition for the treatment of rhinitis comprises the crude drug of following weight portion: 30 grams of Herba Taraxacis, 20 grams of Cortex Phellodendris, 30 grams of Rhizoma Chuanxiongs, 30 grams of Pericarpium Citri Reticulataes, 20 grams of the Rhizoma Pinelliaes, 30 grams of Radix Asteriss, 20 grams of Radix Trichosanthis, 3 grams of Mentholums, 2 grams of artificial Moschuss, 3 grams of Borneolum Syntheticums, 3 grams of diphenhydramine, 3 grams of Camphoras, 4 grams of methyl salicylate, 5 grams of Semen daturae fluid extracts.
Herba Taraxaci: cold in nature, sweet-bitter flavor, has the effect of heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, dampness removing jaundice eliminating.
Cortex Phellodendri: meridian distribution of property and flavor: bitter, cold.Return kidney, bladder, large intestine channel.Effect: heat clearing and damp drying, eliminating fire and detoxication, bring down a fever except steaming.
Rhizoma Chuanxiong: there is the effects such as blood-activating and qi-promoting, wind-expelling pain-stopping, dissipating depression of QI dampness.
Pericarpium Citri Reticulatae: acrid in the mouth, hardship, warm in nature; Return spleen, stomach, lung meridian; Fragrant a surname is loose for gas, has the effect of regulating the flow of Qi and the middle Jiao, drying dampness to eliminate phlegm, diuretic relieving constipation.
The Rhizoma Pinelliae: pungent, temperature.Return spleen, stomach, lung meridian.Energy drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Externally used detumescence pain relieving.
Radix Asteris: nature and flavor are bitter, warm.Enter lung meridian.There is warming the lung, the therapeutic method to keep the adverse QI flowing downwards, expectorant, cough-relieving.Control cough due to wind and cold asthma, asthenia is coughed vomiting bloody pus, sore throat, dysuria.
Radix Trichosanthis: be clearing away heat-fire class medicine, its concrete effect is clearing away heat-fire, promoting the production of body fluid to quench thirst, evacuation of pus detumescence.Cure mainly: control calentura thirsty, quench one's thirst, jaundice, dryness of the lung hemoptysis, carbuncle, hemorrhoid flaccidity.
Mentholum: have refrigerant itching-relieving action; The carminative that can be used as for oral administration, for headache and nose; Pharynx; Laryngitis etc.
Herba Taraxaci, Cortex Phellodendri, Rhizoma Chuanxiong, Pericarpium Citri Reticulatae, the Rhizoma Pinelliae, Radix Asteris, Radix Trichosanthis, Mentholum and artificial Moschus, Borneolum Syntheticum, diphenhydramine, Camphora, methyl salicylate, Semen daturae fluid extract combined effect, rhinitis is had to expelling wind and clearing away heat, dampness removing is sensible, the effect of blood circulation promoting and blood stasis dispelling, therapeutic effect is good, has no side effect.Through clinic trial, effective percentage reaches 95%, has extraordinary promotional value.
During use, the broken rear extraction percolate of each medicated powder is coated with to nose outward.During suitability for industrialized production, make ointment after can adding the things such as rubber, zinc oxide, vaseline, lanoline liquid wax, convenient use.
The specific embodiment
A kind of pharmaceutical composition for the treatment of rhinitis comprises the crude drug of following weight portion: 30 grams of Herba Taraxacis, 20 grams of Cortex Phellodendris, 30 grams of Rhizoma Chuanxiongs, 30 grams of Pericarpium Citri Reticulataes, 20 grams of the Rhizoma Pinelliaes, 30 grams of Radix Asteriss, 20 grams of Radix Trichosanthis, 3 grams of Mentholums, 2 grams of artificial Moschuss, 3 grams of Borneolum Syntheticums, 3 grams of diphenhydramine, 3 grams of Camphoras, 4 grams of methyl salicylate, 5 grams of Semen daturae fluid extracts.

Claims (2)

1. treat a pharmaceutical composition for rhinitis, comprise the crude drug of following weight portion: Herba Taraxaci 20-40 gram, Cortex Phellodendri 15-30 gram, Rhizoma Chuanxiong 20-40 gram, Pericarpium Citri Reticulatae 20-40 gram, Rhizoma Pinelliae 15-30 gram, Radix Asteris 20-40 gram, Radix Trichosanthis 15-30 gram, Mentholum 1-5 shell, artificial Moschus 0.5-4 gram, Borneolum Syntheticum 1-5 gram, diphenhydramine 1-5 gram, Camphora 1-5 gram, methyl salicylate 3-6 gram, Semen daturae fluid extract 3-7 gram.
2. a kind of pharmaceutical composition for the treatment of rhinitis according to claim 1, is characterized in that: the crude drug that comprises following weight portion: 30 grams of Herba Taraxacis, 20 grams of Cortex Phellodendris, 30 grams of Rhizoma Chuanxiongs, 30 grams of Pericarpium Citri Reticulataes, 20 grams of the Rhizoma Pinelliaes, 30 grams of Radix Asteriss, 20 grams of Radix Trichosanthis, 3 grams of Mentholums, 2 grams of artificial Moschuss, 3 grams of Borneolum Syntheticums, 3 grams of diphenhydramine, 3 grams of Camphoras, 4 grams of methyl salicylate, 5 grams of Semen daturae fluid extracts.
CN201310588357.1A 2013-11-21 2013-11-21 Drug composition for treating rhinitis Pending CN103585373A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310588357.1A CN103585373A (en) 2013-11-21 2013-11-21 Drug composition for treating rhinitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310588357.1A CN103585373A (en) 2013-11-21 2013-11-21 Drug composition for treating rhinitis

Publications (1)

Publication Number Publication Date
CN103585373A true CN103585373A (en) 2014-02-19

Family

ID=50075826

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310588357.1A Pending CN103585373A (en) 2013-11-21 2013-11-21 Drug composition for treating rhinitis

Country Status (1)

Country Link
CN (1) CN103585373A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105147889A (en) * 2015-09-02 2015-12-16 安徽金马药业有限公司 Plaster for treating rhinitis
CN105726730A (en) * 2016-02-29 2016-07-06 张忠华 Nasal mucosa antibacterial paste and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552535A (en) * 2012-02-15 2012-07-11 王晓书 Rhinitis plaster and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552535A (en) * 2012-02-15 2012-07-11 王晓书 Rhinitis plaster and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
史春和,韩福谦: "中医药治疗变应性鼻炎研究进展", 《河北中医》, vol. 34, no. 7, 31 July 2012 (2012-07-31), pages 1094 - 1097 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105147889A (en) * 2015-09-02 2015-12-16 安徽金马药业有限公司 Plaster for treating rhinitis
CN105726730A (en) * 2016-02-29 2016-07-06 张忠华 Nasal mucosa antibacterial paste and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101954062B (en) Medicine for treating chronic pharyngitis
CN101934025B (en) Traditional Chinese medicine for clearing away heat and toxic material
CN102988518A (en) Traditional Chinese medicine for treating rhinitis
CN101979022A (en) Chinese medicinal mixture for treating chronic rhinitis
CN103385941B (en) Chinese herbal medicine analgesic moxibustion
CN103169885A (en) Traditional Chinese medicine composition for treating infantile asthma
CN104189180A (en) Traditional Chinese medicine pillow for treating rhinitis
CN103585373A (en) Drug composition for treating rhinitis
CN101015670A (en) Preparation process of traditional Chinese medicine lotion for treating closed trauma
CN103142857B (en) Chinese medicinal granules for treating bronchitis combined emphysema and preparation method thereof
CN103638512A (en) Traditional Chinese medicine for treating acute bronchitis and preparation method thereof
CN103110774B (en) Chinese herbal preparation for treating epistaxis and preparation method thereof
CN102670919A (en) Chinese medicament for treating chronic pyelonephritis
CN103127465B (en) Chinese medicament for treating mammary gland hyperplasia
CN105456980A (en) Antipyretic patch for treating winter cold and fever and preparation method of antipyretic patch
CN105582154A (en) Capsule medicine for treating wind cold induced migraine and preparation method
CN104491328A (en) Ointment for treating crural erysipelas and preparation method for ointment
CN105497155A (en) Traditional Chinese medicine for treating oral leukoplakia
CN104606533A (en) Traditional Chinese medicine decoction for treating pharyngitis
CN103550350A (en) Traditional Chinese medicine paste for treating chronic bronchitis
CN103623161A (en) Traditional Chinese medicine formula for treating chronic bronchitis
CN103520424A (en) Traditional Chinese medicine preparation for treating periodontitis
CN101961453B (en) Traditional Chinese medicine for treating chronic rhinitis
CN101934010B (en) Plaster for treating rheumatic diseases
CN106237208A (en) Chinese medicine pill for the treatment of chronic rhinitis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140219